TRIBE-2 by GONO group: A phase III strategy study in the first- and second-line treatment of unresectable metastatic colorectal cancer (mCRC) patients. Background: Regorafenib is an oral multikinase ...
Relationship of cancer stem cell functional assay and objective response rate of patients with recurrent platinum-resistant ovarian cancer in a randomized trial. Secondary cytoreduction followed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results